BeyondSpring BYSI
NASDAQ BYSI
$0.77 +0.16 (+25.70%)
At close: Sep 10, 2026 · 4:00 PM EDT

BeyondSpring (BYSI) Common Equity (2015 - 2026)

BeyondSpring's (BYSI) quarterly Common Equity came in at -$36.0 million in Q2 2026, down 105.33% year-over-year from $676.0 million in Q2 2025, and down 18.68% quarter-over-quarter from -$30.4 million in Q1 2026.

Analysis

BeyondSpring (BYSI) Common Equity (2015 - 2026) Analysis & Trends

BeyondSpring has disclosed Common Equity across 12 years of filings, most recently posting -$36.0 million for Q2 2026.

  • In Q2 2026, Common Equity fell 105.33% year-over-year to -$36.0 million; the TTM figure through Jun 2026 stood at -$36.0 million (down 105.33% YoY), while the FY2025 annual figure was -$32.2 million, down 125.14% from the prior year.
  • Common Equity came in at -$36.0 million for Q2 2026 at BeyondSpring, down from -$30.4 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $500.0 million in Q3 2025 to a low of -$38.5 million in Q2 2024.
  • Average Common Equity over 5 years is $14.4 million, with a median of -$21.9 million recorded in 2023.
  • Year-over-year, Common Equity sank 422.66% in 2023 and surged 4639.26% in 2025.
  • Over 5 years, Common Equity stood at -$14.1 million in 2022, then sank by 150.94% to -$35.3 million in 2023, then surged by 59.57% to -$14.3 million in 2024, then sank by 125.14% to -$32.2 million in 2025, then slipped by 12.01% to -$36.0 million in 2026.
  • Per Business Quant data, the three most recent Common Equity figures were -$36.0 million in Q2 2026, -$30.4 million in Q1 2026, and -$32.2 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Johnson & Johnson 641.14 Bn 620.38 Bn 17.26 Bn 84.97 Bn
2 AbbVie 451.04 Bn 444.47 Bn 12.70 Bn -5.94 Bn
3 Merck 357.43 Bn 350.29 Bn 12.21 Bn 106.07 Bn
4 Novartis Ag 266.73 Bn 259.04 Bn 11.24 Bn 41.95 Bn
5 Pfizer 157.52 Bn 145.82 Bn 10.94 Bn 85.49 Bn
6 Sanofi 52.14 Bn 44.76 Bn 10.79 Bn 80.86 Bn
7 Revolution Medicines 42.88 Bn 42.88 Bn - 2.61 Bn
8 Incyte 24.70 Bn 20.16 Bn 1.57 Bn 6.34 Bn
9 United Therapeutics 21.47 Bn 18.80 Bn 683.80 Mn 6.40 Bn
10 BeyondSpring 31.51 Mn 31.51 Mn - -36.03 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -36.03 Mn
Mar 31, 2026 -30.35 Mn
Dec 31, 2025 -32.16 Mn
Sep 30, 2025 500.00 Mn
Jun 30, 2025 -17.55 Mn
Mar 31, 2025 -12.67 Mn
Dec 31, 2024 -14.29 Mn
Sep 30, 2024 -11.02 Mn
Jun 30, 2024 -38.55 Mn
Mar 31, 2024 -38.17 Mn
Dec 31, 2023 -35.34 Mn
Jun 30, 2023 -26.16 Mn
Dec 31, 2022 -14.08 Mn
Jun 30, 2022 8.11 Mn
Dec 31, 2021 20.92 Mn
Sep 30, 2021 38.33 Mn
Jun 30, 2021 55.31 Mn
Mar 31, 2021 72.51 Mn
Dec 31, 2020 86.63 Mn
Sep 30, 2020 22.92 Mn